Skip to main content

Table 2 Preoperative fine needle aspiration cytology and postoperative pathological features of patients

From: Identification of serum biomarker panel to differentiate malignant from benign thyroid nodules using multiplex bead assay

 

BTN

MTN

Total

Preoperative FNAC

Bethesda (% risk of malignancy)/BTA

II (0–3%)/Thy2

3

0

3

III (5–15%)/Thy3a

5

1

6

IV (15–30%)/Thy3f

12

6

18

V (60–75%)/Thy4

0

9

9

VI (97–99%)/Thy5

0

4

4

Total

20

20

40

Postoperative pathological diagnosis

Final diagnosis

Colloid nodule

3 (15 %)

40

Adenomatous goiter

6 (30 %)

Follicular adenoma

11 (55 %)

PTC (including FVPTC)

17 (85%)

FTC

3 (15%)

Total

20

20

LN metastasis

Positive

9 (45%)

 

Negative

11 (55%)

Total

 

20

Vascular invasion

Positive

3 (15%)

 

Negative

17 (85%)

Total

 

20

  1. BTN benign thyroid nodule, MTN malignant thyroid nodule, FNAC fine needle aspiration cytology, LN lymph node, PTC papillary thyroid carcinoma, FTC follicular thyroid carcinoma, FVPTC follicular variant of papillary thyroid carcinoma